@inbook {13158,
	title = {Adoption of a Cost-Saving Innovation: Germany, UK and Simvastatin},
	booktitle = {England and Germany in Europe {\textendash} What Lessons Can We Learn from Each Other?},
	year = {2011},
	pages = {11-26},
	publisher = {Nomos Verlag},
	organization = {Nomos Verlag},
	address = {Baden-Baden, Germany},
	abstract = {We examine how the UK and German health care systems responded to a major cost-saving innovation: the availability of generic simvastatin, a cho{\textlnot}lesterol-lowering drug. In the German Social Health Insurance, the generic{\textquoteright}s entry reduced sales volumes for both branded simvastatin (Zocor) and a close substitute, branded atorvastatin (Lipitor/Sortis). In UK, only the sales of branded simvastatin fell whereas the sales of atorvastatin were mostly unaf{\textlnot}fected. We trace these experiences to institutional differences in the two health care systems and to the structure of patient cost-sharing in particular.
},
	author = {McGuire, Thomas and Bauhoff, Sebastian},
	editor = {Klusen, N., and Verheyen, F. and Wagner, C.}
}
